Bioptik Technology Incorporation (TPEX:4161)
22.85
-0.05 (-0.22%)
May 29, 2026, 1:30 PM CST
TPEX:4161 Revenue
Bioptik Technology Incorporation had revenue of 224.29M TWD in the quarter ending March 31, 2026, with 14.60% growth. This brings the company's revenue in the last twelve months to 865.76M, up 2.91% year-over-year. In the year 2025, Bioptik Technology Incorporation had annual revenue of 837.19M, down -3.25%.
Revenue (ttm)
865.76M
Revenue Growth
+2.91%
P/S Ratio
1.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 837.19M | -28.14M | -3.25% |
| Dec 31, 2024 | 865.34M | 36.83M | 4.45% |
| Dec 31, 2023 | 828.50M | 60.75M | 7.91% |
| Dec 31, 2022 | 767.75M | 29.86M | 4.05% |
| Dec 31, 2021 | 737.89M | 252.29M | 51.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.81B |
| Cowealth Medical Holding | 2.86B |
| OK Biotech | 1.53B |
| Dynamic Medical Technologies | 1.38B |
| AViTA | 952.73M |
| Diamond Biotechnology | 501.49M |
| Wiltrom | 312.43M |
| Taiwan Biomaterial | 179.17M |